1314395-91-9

Basic information

• Product Name: benzyl 2-methyl-5-oxopiperidine-1-carboxylate
• Synonyms: benzyl 2-methyl-5-oxopiperidine-1-carboxylate;2-Methyl-5-Oxo-Piperidine-1-Carboxylic Acid Benzyl Ester;2-Methyl-5-Oxo-Piperidine-1-Carboxylic Acid Benzyl Ester(WX625008)
• CAS NO: 1314395-91-9
• Molecular Formula: C₁₄H₁₇NO₃
• Molecular Weight: 247.28968
• Mol File: 1314395-91-9.mol
• Article Data: 15

Chemical Properties

• Boiling Point: 388.1±42.0 °C(Predicted)
• Appearance: /
• Density: 1.164±0.06 g/cm3(Predicted)
• PKA: -1.69±0.40(Predicted)
• CAS DataBase Reference: benzyl 2-methyl-5-oxopiperidine-1-carboxylate(CAS DataBase Reference)
• NIST Chemistry Reference: benzyl 2-methyl-5-oxopiperidine-1-carboxylate(1314395-91-9)
• EPA Substance Registry System: benzyl 2-methyl-5-oxopiperidine-1-carboxylate(1314395-91-9)

Safety Data

• Hazardous Substances Data: 1314395-91-9(Hazardous Substances Data)

Upstream product

• 1314396-07-0 (±)-benzyl 5-hydroxy-2-methylpiperidine-1-carboxylate 
• 54751-93-8 6-methyl-3-piperidinol 
• 501-53-1 benzyl chloroformate 

Downstream Products

• 1431473-04-9 benzyl (2R,5R)-5-hydroxy-2-methylpiperidine-1-carboxylate 
• 1431472-56-8 2-{[(3R,6R)-6-methyl-1-[(2-pyrimidin-2-ylphenyl)carbonyl]piperidin-3-yl]oxy}pyridine-4-carbonitrile 
• 1431472-58-0 2-{[(3R,6R)-6-methyl-1-{[2-(5-methyl-1,2,4-oxadiazol-3-yl)phenyl]carbonyl}piperidin-3-yl]oxy}pyridine-4-carbonitrile 
• 1314396-07-0 (±)-benzyl 5-hydroxy-2-methylpiperidine-1-carboxylate 
• 1431473-24-3 (2R,5S)-benzyl 5-hydroxy-2-methylpiperidine-1-carboxylate 
• 1431473-03-8 benzyl (2R,5R)-2-methyl-5-{[(4-nitrophenyl)carbonyl]oxy}piperidine-1-carboxylate 
• 1431473-05-0 tert-butyl (2R,5R)-5-hydroxy-2-methylpiperidine-1-carboxylate 
• 1431472-54-6 2-{[(3R,6R)-6-methyl-1-{[2-(2H-1,2,3-triazol-2-yl)phenyl]carbonyl}piperidin-3-yl]oxy}pyridine-4-carbonitrile 
• 1609468-17-8 benzyl 5-[2-(tert-butoxycarbonyl)hydrazino]-2-methylpiperidine-1-carboxylate 
• 1609468-18-9 benzyl 5-hydrazino-2-methylpiperidine-1-carboxylate 
• 1609466-98-9 5-amino-1-[(3R,6S)-1-cyano-6-methylpiperidin-3-yl]-3-[4-(2,4-difluorophenoxy)phenyl]-1H-pyrazole-4-carboxamide 
• 1609466-99-0 5-amino-1-[(3S,6R)-1-cyano-6-methylpiperidin-3-yl]-3-[4-(2,4-difluorophenoxy)phenyl]-1H-pyrazole-4-carboxamide 
• 1616373-56-8 4-(methylsulfanyl)-2-{[(3R,6R)-6-methyl-1-{[2-(2H-1,2,3-triazol-2-yl)phenyl]carbonyl}piperidin-3-yl]oxy}pyridine-3-carbonitrile 
• 1612786-29-4 (2R,5S)-benzyl 2-methyl-5-((methylsulfonyl)oxy)piperidine-1-carboxylate 

Relevant articles and documents

5-AMINOPYRAZOLE CARBOXAMIDE DERIVATIVE AS BTK INHIBITOR AND PREPARATION METHOD AND PHARMACEUTICAL COMPOSITION THEREOF

The present application discloses novel 5-aminopyrazole carboxamide compounds as shown in formula (I), and stereoisomers, pharmaceutically acceptable salts, solvates, or prodrugs thereof. In addition, the present application further discloses a method for the preparation of the compounds, a pharmaceutical composition comprising a compound of the invention and the use of the compounds.

THIOETHER-PIPERIDINYL OREXIN RECEPTOR ANTAGONISTS

The present invention is directed to thioether-piperidinyl compounds which are antagonists of orexin receptors. The present invention is also directed to uses of the thioether-piperidinyl compounds described herein in the potential treatment or prevention

2-PYRIDYLOXY-3-ESTER-4-ETHER OREXIN RECEPTOR ANTAGONISTS

The present invention is directed to 2-pyridyloxy-3-ester-4-ether compounds which are antagonists of orexin receptors. The present invention is also directed to uses of the 2-pyridyloxy-4-ether compounds described herein in the potential treatment or prev